Press "Enter" to skip to content

US company won’t supply life-saving drug for Russian children

An Eli Lilly subsidiary has halted deliveries to Russia of its widely used insulin product

By RT International

The supply of Humalog-brand insulin produced by Eli Lilly has practically run out in Russia, the Kommersant newspaper has reported. Most of the drug’s customers in the country are children with type-1 diabetes.

In March 2022, following the start of Russia’s military operation in Ukraine, Lilly announced that it would stopping the export of “non-essential” drugs to Russia, such as the erectile dysfunction pill Cialis, but that cancer and diabetes drugs would be unaffected.

Since then, the US pharma giant delegated its Russia operations to a Swiss subsidiary, Swixx BioPharma. According to Kommersant, that company notified Russian authorities in February that it was halting new deliveries of Humalog, also known as insulin lispro. No reason was given for the move.

Russia’s drug monitoring body Roszdravnadzor said that as of Monday, there were more than a million doses of insulin lispro in circulation, “which meets the annual need for the drug.”

Read Full Article Here…(

Home | Caravan to Midnight (

Live Stream + Chat (

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: